Roche Holding traded at 325.25 this Wednesday May 18th, increasing 2.90 or 0.90 percent since the previous trading session. Looking back, over the last four weeks, Roche Holding gained 13.78 percent. Over the last 12 months, its price rose by 6.13 percent. Looking ahead, we forecast Roche Holding to be priced at 311.83 by the end of this quarter and at 290.45 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
325.25
Daily Change
0.90%
Yearly
6.13%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.14 -1.62 -1.05% 32.19%
Alcon AG 71.42 -0.06 -0.08% 15.57%
Almirall SA 10.24 -0.21 -2.01% -27.99%
Amgen 244.39 -0.96 -0.39% -1.71%
Artemis Alpha 312.00 3.50 1.13% -27.94%
AstraZeneca 10,424.00 -64.00 -0.61% 31.05%
Bayer 64.05 -0.07 -0.11% 15.05%
Biogen 199.72 -3.18 -1.57% -29.11%
Bristol-Myers Squibb 77.95 -0.28 -0.35% 18.91%
Fresenius Medical Care 56.90 0.04 0.07% -14.38%
Fresenius 32.79 -0.46 -1.38% -26.21%
Genmab 2,160.00 60.00 2.86% -6.90%
Gilead Sciences 63.33 0.15 0.24% -7.55%
Galapagos 54.26 -0.98 -1.77% -9.26%
GRIFOLS 19.99 0.36 1.81% -14.56%
GlaxoSmithKline 1,788.90 2.70 0.15% 30.88%
Hikma Pharmaceutical 1,745.00 18.50 1.07% -27.38%
Eli Lilly 295.57 -5.83 -1.93% 50.41%
Lonza Group 550.60 -2.20 -0.40% -2.24%
H Lundbeck A/S 166.80 -1.00 -0.60% -16.35%
Merck 164.55 -0.05 -0.03% 15.23%
Merck & Co 92.48 -0.53 -0.56% 16.53%
Novartis 87.80 0.39 0.45% 10.14%
Orion 36.59 -0.16 -0.44% -1.19%
Pfizer 50.72 -0.62 -1.21% 27.34%
Philips 23.83 -0.09 -0.36% -47.72%
Recordati 41.56 -0.31 -0.74% -8.30%
Regeneron Pharmaceuticals 665.09 -2.47 -0.37% 30.34%
Roche Holding 325.25 2.90 0.90% 6.13%
Sanofi 100.74 0.82 0.82% 16.06%
UCB 88.78 -0.22 -0.25% 13.04%

Indexes Price Day Year
CH20 11613 -117.00 -1.00% 5.14%

Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.